We are live on ! Find out more
TOI icon

The Oncology Institute
TOI

39 hedge funds and large institutions have $108M invested in The Oncology Institute in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 23 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 8

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

8% more funds holding

Funds holding: 36 → 39 (+3)

2.5% more ownership

Funds ownership: 29.89% → 32.39% (+2.5%)

2% less capital invested

Capital invested by funds: $111M → $108M (-$2.53M)

Holders
39
Holders Change
+3
Holders Change %
+8.33%
% of All Funds
0.67%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
5
Increased
23
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.54M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.67M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.62M
4
Northern Trust
Northern Trust
Illinois
+$655K
5
State Street
State Street
Massachusetts
+$526K

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$899K
2
Millennium Management
Millennium Management
New York
-$613K
3
VCIM
Velan Capital Investment Management
Georgia
-$301K
4
DM
Deerfield Management
New York
-$136K
5
SCM
Saba Capital Management
New York
-$113K
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$51K -$28.4K -4,826 -31%
Allspring Global Investments
27
Allspring Global Investments
North Carolina
$50K +$64.2K +10,919 New
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$49K +$61.9K +10,525 New
AB
29
Amalgamated Bank
New York
$23K +$11.1K +1,894 +64%
Legal & General Group
30
Legal & General Group
United Kingdom
$19K +$3.14K +534 +15%
TRCT
31
Tower Research Capital (TRC)
New York
$8K -$11.8K -2,012 -55%
Barclays
32
Barclays
United Kingdom
$7K +$3.14K +534 +57%
UBS Group
33
UBS Group
Switzerland
$7K +$6.3K +1,071 +209%
AIP
34
Ameritas Investment Partners
Nebraska
$6K – – –
Morgan Stanley
35
Morgan Stanley
New York
$6K +$1.3K +222 +18%
Wells Fargo
36
Wells Fargo
California
$3K +$576 +98 +21%
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$3K +$2.92K +496 +468%
Citigroup
38
Citigroup
New York
$2K -$3.58K -608 -53%
CS
39
Credit Suisse
Switzerland
$1K -$312 -53 -22%
Millennium Management
40
Millennium Management
New York
– -$613K -121,145 Closed
PCM
41
Penserra Capital Management
California
– -$10K -2,121 Closed
1
2

TOI Hedge Fund Activity: Q3 2022 in Review

39 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute (TOI) for Q3 2022, worth a combined $108M — down 2.3% from $111M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new TOI positions and 2 closed out — a net gain of 3 holders — while 23 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock, adding an estimated $4.54M. The largest seller was Redmile Group, cutting an estimated $899K.

  • 39 institutional investors held The Oncology Institute (TOI) as of Q3 2022, up from 36 in Q2 2022.
  • Funds reported $108M of The Oncology Institute stock for Q3 2022, down 2.3% quarter-over-quarter.
  • 5 funds opened new The Oncology Institute positions in Q3 2022 and 2 closed out, a net change of +3 holders.
  • The largest The Oncology Institute buyer in Q3 2022 was BlackRock, an estimated $4.54M added.
  • The largest The Oncology Institute seller in Q3 2022 was Redmile Group, an estimated $899K sold.

Based on aggregated 13F filings for Q3 2022.